DeAngelo, DJ; Spencer, A; Fischer, T et al.
Activity of Oral Panobinostat (LBH589) in Patients with MyelofibrosisBLOOD. Bd. 114. H. 22. 2009 S. 1132-1132
Jin, N; Roark, CL; Miyahara, N et al.
Allergic Airway Hyperresponsiveness-Enhancing gamma delta T Cells Develop in Normal Untreated Mice and Fail to Produce IL-4/13, Unlike Th2 and NKT CellsJOURNAL OF IMMUNOLOGY. Bd. 182. H. 4. 2009 S. 2002-2010
Schrezenmeier, H; Feldmann, U; Ottinger, H et al.
Allogeneic Stem Cell Transplantation for Acquired Aplastic Anemia: Better Outcome with Bone Marrow as Compared to Peripheral Blood in HLA-Matched Sibling Donor Transplantation and Improved Outcome Over Time After Matched Unrelated Donor Transplantation. A Retrospective Analysis of Transplants Reported to the German Registry for Stem Cell Transplantation (DRST)BLOOD. Bd. 114. H. 22. 2009 S. 360-361
Pfeiffer, T; Schleuning, M; Eder, M et al.
Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with Normal Karyotype: A Risk Factor Analysis in 247 Patients, Based On Molecular Markers and Stage at Transplantation.BLOOD. Bd. 114. H. 22. 2009 S. 497-497
Kronig, H; Hofer, K; Conrad, H et al.
Allorestricted T lymphocytes with a high avidity T-cell receptor towards NY-ESO-1 have potent anti-tumor activity.Int J Cancer. Bd. 125. H. 3. 2009 S. 649-55
Viscoli, C; Herbrecht, R; Akan, H et al.
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients.J Antimicrob Chemother. Bd. 64. H. 6. 2009 S. 1274-81
Joetham, A; Takeda, K; Okamoto, M et al.
Antigen specificity is not required for modulation of lung allergic responses by naturally occurring regulatory T cells.J Immunol. Bd. 183. H. 3. 2009 S. 1821-7
Michallet, M; Dreger, P; Sutton, L et al.
Autologous Hematopoietic Stem Cell Transplantation (autoHSCT) in CLL: First Results of An EBMT Randomized Trial Comparing Autotransplant Versus Wait and WatchBLOOD. Bd. 114. H. 22. 2009 S. 361-361
Harbeck, N; Schmidt, M; Harter, P et al.
BIBW 2992, a Novel Irreversible EGFR/HER1 and HER2 Tyrosine Kinase Inhibitor for the Treatment of Patients with HER2-Negative Metastatic Breast Cancer after Failure of No More Than Two Prior ChemotherapiesCANCER RESEARCH. Bd. 69. H. 24. 2009 S. 785S-786S
Kolbe, K; Karstens, A; Krämer, I
Busulfan systemic exposure after oral administration of extemporeanously prepared high-dose busulfan capsulesJ Oncol Pharm Pract. Bd. 16. H. 3. 2009 S. 151-9